Lindahl advises on Swedencare's acquisition of Summit

Swedencare develops, produces, and sells premium products for the global and rapidly growing market in animal health, focusing on cats, dogs, and horses. With headquarters in Malmö, the products are sold in approximately 70 countries through veterinarians, pet shops, and online. The company's extensive distribution network includes subsidiaries in nine countries as well as an international network of resellers.

Summit develops, produces, and sells Animal Health Specials exclusively to veterinarians in the United Kingdom and Hong Kong. Summit's robust product portfolio primarily focuses on small animals but has recently expanded to include horses. Several new products will be introduced in the coming years. Summit's customer base consists of over 5,500 veterinary clinics in the United Kingdom.

Lindahl's team comprised Johan Herrström, Alex Malta, Christian Sundén, Gabriel Miller, and Emanuel Franzen.

Lindahl worked on the acquisition together with Reynolds Porter Chamberlain LLP (RPC), member of the same global network as Lindahl; Terralex.

For more information, read Swedencare's press releases:

24 March 2025: Swedencare AB (publ) acquires Summit Veterinary Pharmaceuticals Limited, a leader in the UK’s thriving Animal Health Specials Market

1 April 2025: Swedencare AB (publ) has completed the acquisition of av Summit Veterinary Pharmaceuticals Limited